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High-throughput microfluidic devices for cytotoxicity screening are currently in high demand because 
they take much less turnaround time and cost only a fraction to fabricate comparing to the traditional 
animal testing method. However, most of the previous works have failed to construct a reliable drug 
testing platform since the largely exploited material - polydimethylsiloxane (PDMS) – absorbs even 
small hydrophobic molecules, such as anti-cancer drugs. Several previous studies have switched to 
thermoplastics, including poly(methyl methacrylate) (PMMA), for its inherent impermeability to small 
molecules. Still, there is no record shown to integrate these resins with polyethylene terephthalate 
(PETE) track-etched membrane to form a fully compartmentalized chip. This study reports a novel use 
of (3-glycidyloxypropyl)trimethoxysilane (GLYMO) to achieve an irreversible bonding of PMMA to 
PETE membranes for developing a drug-testing model. Briefly, the PMMA substrates engraved with 
microfluidic channels were functionalized with air plasma for 1 min and assembled with a 5% GLYMO 
- coated PETE membrane, followed by clamping and heating in an oven at 100 °C for 2 min. The 
fabricated device endured up to 135kPa in gauge pressure and 1.97 × 107 kg m−2 in shear force before 
showing any signs of liquid leakage. Drug testing efficacy was successfully validated as human lung 
adenocarcinoma cells showed more reliable cytotoxicity results for vincristine when cultured in the 
PMMA devices than those in the PDMS counterpart. Overall, our bonding approach was proven to be 
more advantageous over the fabrication methods using PDMS to construct a highly robust and reliable 
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Figure 1. (A) Schematic diagram of the overall chip assembling process. (B) Microfluidic channels 
are engraved on the PMMA substrates using a CNC machine. (C) 5% GLYMO-treated PETE membrane 
is sandwiched between two layers of air plasma-treated PMMA substrates. (D) Tygon tubes are 
connected to the inlets and outlets of a fully bonded chip for ease of fluid manipulation. Scale bar, 1cm. 
Figure 2. A schematic diagram of chemical bonding between PMMA substrates and porous PETE 
membrane. (A) PETE membrane is first oxidized by air plasma treatment and coated with 5% GLYMO 
solution. (B) PMMA substrates (both upper and lower layer) are air-plasma treated (C) GLYMO-coated 
PETE membrane is brought into contact with oxidized PMMA substrates to form an irreversible 
bonding under thermal catalyst.  
Figure 3. Surface characterization of PETE membrane after chemical treatment. (A)-(I) SEM 
images of the porous PETE membrane when in bare condition, air plasma-treated, and GLYMO-treated. 
Scale bar, 100 µm (A), (D), (G); 50 µm in (B), (E), (H); 10 µm in (C), (F), (I). Contact angles were also 
measured (J) for three same conditions.   
Figure 4. (A) XPS analysis of the GLYMO - treated PETE membrane. (B) The SiC bond is derived 
from the GLYMO molecules. (C), (D) The C 1s and O 1s spectra showing multiple peaks represent 
polyester on the PETE surface. (E) The Si 2s and Si 2p peaks are shown because of the silane coupling 
reaction. 
Figure 5. FT-IR analysis of (A) GLYMO-treated PETE membrane and (B) APTES-treated PETE 
membrane compared against air-plasma treated PETE membrane, respectively. (C) FT-IR analysis of  
APTES-treated PMMA substrate versus air plasma-treated PETE membrane.  
Figure 6. Validation of robust bonding. (A) The bonding strength between PMMA and PETE 
membrane was measured in terms of shear stress. GLYMO-coated PETE bonded to hydroxylated 
PMMA substrates showed the highest resistance to shear force compared to other bonding methods. 
(B)(C)(D) The fabricated device was confirmed to be leakage-free by using a dye-penetration test. 
Figure 7. Diagrammatic top-view representations of the microfluidic channels and PETE 
membranes assembled with PMMA and PDMS. Scale bars, 400 μm. (A) The flat PETE membrane 
in the PMMA – PETE device. (B) The irregularly wrinkled PETE membrane in the PDMS – PETE 
device. (C) Confocal microscopic images (orthogonal section display mode) showing calcein-AM-
stained human lung adenocarcinoma cells (green) cultured for 2 days on PETE membrane in the PMMA 
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and PDMS devices, respectively. The two inset panels at the top and right sides of the images depict the 
longitudinal and lateral cross-sectional views of the cells cultured on the membrane in the PMMA and 
PDMS devices, respectively. 
 
Figure 8. Small molecule absorption degree evaluation using dye-penetration test. (A) Rhodamine 
B solution flowed through the PDMS-PETE and PMMA-PETE channel for 4 to 16 hours. The 
fluorescence images captured from the top view shows the dye solution absorbed into the substrates at 
each different time point. Neither PMMA nor PETE absorbed the rhodamine B dye while the PDMS 
significantly absorbed the dye. The fluorescence intensity of the PETE membrane (bottom panel of A) 
was measured after washing out the channel with a buffer solution to remove residual rhodamine B dyes 
in the channel. Scale bar: 200 µm. (B) The quantitative comparison of rhodamine B absorbed into the 
PDMS channel, the PMMA channel, and the PETE membrane, respectively.  
 
Figure 9. Cytotoxicity testing of Vincristine (at 300nM and 1 μM concentration) on human lung 
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(ii) Hydroxylated PMMA (OH-PMMA) to APTES-PETE membrane, (iii) APTES-PMMA to GLYMO-

































Over the past decades, the development and testing stage of the drug pipeline has been heavily 
constrained due to the rigorous regulation and expensive production cost, resulting in very few 
medicines making to the market each year1. This burden is only worsened due to the upsurge of drug 
discovery services. According to a recent report, its market size is forecasted to expand exponentially, 
reaching an estimated value of up to USD 21.4 billion in 20252. Despite many efforts toward 
outsourcing analytical testing and clinical trials, keeping up with such enormous demand remains 
extremely challenging to this day.  
A potential solution to overcome this difficulty would be screening drugs through a lab-on-a-chip 
platform. Owning to their miniatured scale, the microfluidic devices allow manipulation of small 
sample volume with precise control, making them an excellent choice for throughput chemical and 
biological assays3. Many have attempted to construct drug testing models using microfluidic approaches 
and obtained certain successes. For example, Bo et al. aligned quartz substrate-embedded microwell 
array containing sol-gel bioreactor with a cell culture chamber to achieve a compact drug metabolite 
profiling system. Acetaminophen (AP) was introduced into the device and the corresponding viability 
of human liver cancer cells (HepG2) on the bottom channel was then collected and analyzed4. Jatz et al. 
utilized a gradient generator complex to expose mouse embryo cells (Balb/c 3T3) and human lung 
carcinoma cells (A549) to various concentrations of celecoxib (Celbx)/ 5-fluorouracil (5-FU) for as 
long as 48 hrs5. Although instrumental in analyzing the toxic effect of drugs, most of these testing 
models are unreliable because of the device materials. Among many others, poly(dimethylsiloxane) 
(PDMS) is the most extensively used polymer for prototyping microfluidic chips because of the benefits 
it offers such as facile sealing and optical transparency6. However, PDMS substrates are prone to absorb 
small hydrophobic molecules like anti-cancer drugs, so partitioning of molecules into PDMS chip can 
significantly change solution concentrations and could potentially alter experimental outcomes7.  
To this end, many researchers have employed thermoplastic materials such as polymethylmethacrylate 
(PMMA), polycarbonate (PC), cyclic olefin copolymer (COC) as an alternative to conventional silicon 
or glass material. These resins present rigid mechanical property, high compatibility to electrophoresis, 
and strong resistance to chemicals and solvents8, which thereby make them a better fit for cytotoxicity 
testing of drugs, compared to the PDMS-based microfluidic setting.  
To construct a fully compartmentalized microfluidic device from thermoplastic resin, several bonding 
methods were previously explored. These include thermal bonding9, thermal fusion10, microwave 
bonding11, adhesive bonding12, and solvent bonding13, etc. Although thermal bonding is the most widely 
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used method, high temperature and pressure often can distort the geometry of the micro-scaled channels. 
On the other hand, solvent-assisted thermal bonding enables the reservation of channel structure as the 
bonding occurs at a much lower temperature. This is because the chemical linker acts as a plasticizer to 
reduce glass transition temperature on the surface of the thermoplastic. Still, previous studies mostly 
focused on exploiting chemical reagent like  (3-aminopropyl)triethoxysilane APTES, (3-
glycidyloxypropyl) trimethoxysilane (GLYMO), to achieve an irreversible bonding between 
thermoplastic substrates, but not between the substrate to porous polyethylene terephthalate (PETE) 
track-etched membrane, which is crucial for exchange of cellular signals between chambers.  
To address these unmet challenges, we developed a simple bonding method of PMMA to porous PETE 
membrane using coupling reagent GLYMO for a compartmentalized drug testing model. We further 
validated our model’s efficacy by obtaining the viability of human lung cancer cells when exposed to 
the anti-cancer drug vincristine. Our proposed method is promising in lowering the entry barrier for 
prototyping microfluidic chips for cytotoxicity tests of drugs. 
 
2. Materials and method 
 
2.1 Microfluidic channel design and fabrication   
Microfluidic channel dimensions (width × height x length ; 800 μm × 300 μm x 800 μm) were outlined 
in computer-aided design software AutoCAD and encoded before being directly engraved on PMMA 
substrates (width × height × thickness; 5 cm × 10 cm × 2 mm) using computer numerical control (CNC) 
machine (David 3020C, David, Incheon, South Korea). The resulting micropatterns include one cell-
culture channel on the lower layer; two through-hole inlets (D = 1.58 mm), two through-hole outlets  
(D = 1.58 mm), and a single cell culture channel on the upper channel. The engraved PMMA substrates 
were then washed with isopropanol (IPA, Samchun Pure Chemical, Gyeonggido, South Korea), 
deionized (DI) water, and dried with pressurized nitrogen gas. To remove any remaining milling marks, 
we added 2.5 μL of ethanol (94%) on the microfluidic channels and flipped the PMMA upside down 
before placing it on a glass slide inside a convection oven (C-D0D1, Changshin Science, Gyeonggido, 
South Korea) at 100°C for 2 minutes. Since sudden temperature change may result in a crack inside the 
device’s channels, the PMMA substrates are stored in a convection oven at 60°C for around 20 mins 




Figure 1. (A) Schematic diagram of the overall chip assembling process. (B) Microfluidic channels are 
engraved on the PMMA substrates using CNC machine. (C) 5% GLYMO-treated PETE membrane is 
sandwiched between two layers of air plasma-treated PMMA substrates. (D) Tygon tubes are connected 











2.2 Chemical bonding strategy 
Hydrophobic track-etched PETE membrane (1 μm pore size, SterliTech, Kent, WA, USA) was trimmed 
to fit the PMMA substrates (width x length; 3.5 cm x 3.5 cm) and subsequently rinsed with IPA, DI 
water before gently blow-dried with pressurized nitrogen gas. PETE membrane was oxidized with air 
plasma treatment (80 W, 50 kHz Cute-1MPR, Femto Science, Gyeonggido, South Korea) for 1 min, so 
the surface was rendered hydrophilic. It was then further modified chemically by being immersed in 
GLYMO solution (5 wt%, dissolved in ethanol (99%), Sigma-Aldrich, MO, USA). The chemical flask 
was placed on a hot plate at 100°C for 40 mins. In the meantime, previously machined PMMA substrates 
(upper and lower layer) were cooled to room temperature for 5 mins and oxidized via air plasma (80 W, 
50 kHz) for 1 min. To assemble a complete device, we sandwiched a GLYMO-soaked PETE membrane 
in between the upper and lower PMMA layer and secured with paper clamps on sides after confirming 
the channels’ borders were well aligned under an LCD digital microscope (1-600X, Junefor, China). 
The whole device was placed inside a convection oven at 100°C for 2 mins. Under thermal catalyst, 
hydroxyl groups generated on the surfaces of PMMA substrates would couple with epoxide groups 
from GLYMO coated PETE membrane to form an irreversible bonding. The bonded device was let 
dried in a convection oven at 60 °C for no more than 24 hrs and finally stored at room temperature until 
the next use. Tygon tubes (ID 0.508 mm × OD 1.524 mm, Saint-Gobain PPL Corp., USA) were glued 
to the inlets and outlets using 5-minute epoxy glue (Loctite, OH, USA) for further flow manipulation 
inside the microfluidic device (Fig.2). In addition to this, we also compared other chemical 
functionalization techniques (ii, APTES-PETE to OH-PMMA and iii, GLYMO-PETE to APTES-
PMMA) and alternative substrates to PMMA, such as PDMS (iv, GLYMO-PETE to OH-PDMS) to 
prove the superiority of the proposed method (Table 1). The topological integrity of the PETE 
membrane surface was assessed post-treatment using Scanning electron microscopy (SEM) images 
(S4800, Hitachi High Technologies, USA). Chemical composition was evaluated using X-ray 
photoelectron spectroscopy (XPS, K-alpha, Thermo Fisher, Seoul, South Korea) and FT-IR 
spectroscopy (Cary 670-IR FT-IR Air-Bearing Spectrometer, Agilent Technologies, CA, USA) while 
contact angle was estimated using contact angle measurements (Phoenix 300, SEO – Surface Electro-











Figure 2. A schematic diagram of chemical bonding between PMMA substrates and porous PETE 
membrane. (A) PETE membrane is first oxidized by air plasma treatment and coated with 5% GLYMO 
solution. (B) PMMA substrates (both upper and lower layer) are air-plasma treated (C) GLYMO-coated 
PETE membrane is brought into contact with oxidized PMMA substrates to form an irreversible 





Table 1. Summary of chemical bonding strategies. We investigate the bonding of (i) Hydroxylated 
PMMA (OH-PMMA) to GLYMO-PETE membrane, and for comparison, we also evaluate bonding of 
(ii) Hydroxylated PMMA (OH-PMMA) to APTES-PETE membrane, (iii) APTES-PMMA to GLYMO-





2.3 Cell culture 
For sterilization, the microfluidic channels were flushed with ethanol (70%) thoroughly three times to 
eliminate any remaining chemical residues post-treatment. The channels were sequentially rinsed with 
phosphate-buffered saline (PBS) and cell culture medium. Ham's F12 medium (supplemented with 10% 
fetal bovine serum and 1% penicillin-streptomycin, Welgene, Gyeongsangbuk-do, South Korea) was 
used when culturing human lung adenocarcinoma cells (A549, ATCC®  CCL-185™) and endothelial 
cell medium (supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin, Sciencell, 
CA, USA) was used when culturing primary human umbilical vein endothelial cells (HUVEC) (Lonza, 
Switzerland). To further enhance the cell adhesion, the channels were coated with fibronectin (15 μL 
mL−1 in PBS) and collagen (20 μL mL−1 in PBS) in an incubator (37 °C, 5% CO2 gas) for 1 hr, 
respectively. Cancer cells (A549) and primary cells (HUVEC) were chosen to prove the versatility and 
compatibility of our fabricated microfluidic device with different cell types. When reached 70% 
confluency, cells were washed with PBS, trypsinized, and the centrifuged cell pellet was resuspended 
into media at 1.0 x 106 cells per mL concentration. The cell solution was gently loaded through the 
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Typgon tube connected at the inlet port and manually pumped through the bottom channel until the 
solution reaches the outlet. The microfluidic device was inverted and kept inside an incubator for 2 hrs 
to allow cell attachment on the upper PETE membrane layer. After confirming that cells are firmly 
seeded, media was flowed through both channels at a flowrate of 2 μL min−1 using a syringe pump 
(Fusion 200, Chemyx Inc., USA). For cell visualization, we added calcein acetoxymethyl ester (calcein-
AM) solution (2 μM in PBS) to the bottom channel and incubated at room temperature for 40 minutes, 
then observed using a confocal microscope (LSM 780 Configuration 16 NLO; Carl Zeiss, USA). 
Optical slicing along the z-axis was carried out to recreate the cell monolayer cultured on PETE 
membrane and obtain their spatial distribution in 3D. 
 
2.4 Bonding strength measurement  
The integrity and stability of the bonding between PMMA and PETE membrane were evaluated using 
uniform transmembrane pressure (UTP) shear test (4000 Plus Bondtester, Nordson Dage, OH, USA) 
(shear height: 20 μm, test speed: 500 μm s−1, maximum cartridge weight: 200 kg). The bonded 
microfluidic chip was fitted tightly into the sample holder and cartridge weight was increased over 
time until the upper PMMA layer slid off the PETE membrane while the lower PMMA layer 
remained attached to the porous membrane (Fig.3). The shear stress was obtained by dividing the 
failed loading weight by the bonding area (width x length; 3.5 cm x 3.5 cm). For comparison, we also 
evaluated other bonding strategies as shown in Table 1, where (i) hydroxylated PMMA (OH-PMMA) 
was bonded to APTES-PETE membrane and (iii) APTES-PMMA was bonded to GLYMO-PETE 
membrane. The test was performed for at least 3 trials per sample and conducted inside a specialized 
laboratory to eliminate the nuanced change in temperature, moisture, or contact with any solvents or 
fluids that might influence the result. For the leakage test, we filled the chip with color-dyed solutions 
(red and green) through each upper and lower microfluidic channel, and progressively increasing the 
inlet pressure every 20 seconds with a constantly closed outlet. The maximum internal pressure was 
recorded before the liquid burst outside of the channel using a pressure sensor (Harvard Apparatus, 
USA).  
 
2.5 Small molecule absorption    
To determine the small molecule absorption by PDMS or PMMA substrates, dye-penetration testing 
was performed. In detail, rhodamine B (1mM) solution was flowed continuously through both 
microfluidic channels, at a flow rate of 2 μL/min for 16 hrs. Fluorescence images were obtained every 




2.6 Cytotoxicity testing of drug 
Vincristine was chosen for the cytotoxicity testing because of its extensive use in treating several cancer. 
To prepare the drug solution, Vincristine (Sigma-Aldrich, USA) was dissolved in distilled water to a 
concentration of 5 mM. It was further diluted in the culture medium to achieve a concentration of 300 
nM and 1 μM. Prepared drug solution then flowed through the lower channel of the microfluidic device 
at a flow rate of 25 μL/hr for 48 hrs. After drug treatment, cells were stained with fluorescence dyes for 
viability assessment, specifically live cells were labeled with Hoechst (Sigma-Aldrich, USA) while 
dead cells were labeled with propidium iodide (PI) (Sigma-Aldrich, USA). The recommended 
concentration from the live/dead kit (Sigma-Aldrich, USA) was followed, where 1 μg/ml of PI and 0.5 
μg/ml of Hoechst was added to the culture medium and infused into the cell channel for 40 mins at 
room temperature. Before fluorescent imaging, PBS rinsing and paraformaldehyde (PFA) fixation was 
each performed for 15 mins before fixating the cells. At least three random spots within the microfluidic 
channel were chosen and images were captured at 10× magnification was using a confocal microscope 
(LSM 780 Configuration 16 NLO). The images were analyzed using an image processing software 
(Imaris, Bitplane; http://www.bitplane.com) and then calculated using equation (1). 
 
Statistical analysis 
The results are presented as an average of at least triplicate samples ± standard error means depicted 
by error bars in all of the graphs. Significant differences in all data were determined using the two-









𝑁𝑜.  𝑜𝑓 𝑏𝑙𝑢𝑒 𝑜𝑏𝑗𝑒𝑐𝑡𝑠 −𝑁𝑜.  𝑜𝑓 𝑟𝑒𝑑 𝑜𝑏𝑗𝑒𝑐𝑡𝑠
𝑁𝑜.  𝑜𝑓 𝑏𝑙𝑢𝑒 𝑜𝑏𝑗𝑒𝑐𝑡𝑠
]𝑜𝑝𝑡𝑖𝑐𝑎𝑙 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑠
𝑁𝑜.  𝑜𝑓 𝑜𝑝𝑡𝑖𝑐𝑎𝑙 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑠
× 100 %  (1) 
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3. Result and discussion 
 
3.1 Bonding strategy and experimental validation 
Air plasma treatment is often used as a means of adding biological relevant functional groups like 
hydroxyl groups (-OH) or other oxygen-containing groups (e.g., –(C=O)H, -(C=O)OH, etc.) to material 
surfaces. As a result, plasma-treated surfaces such as PETE and PMMA become more readily available 
to react when brought into contact with other substrates. GLYMO is widely employed as a coupling 
agent or an adhesion promoter because a terminal epoxide group is reactive toward common 
nucleophiles, including –NH2, -OH, and –SH, while the trimethoxy silane group can readily form C-O-
Si bonds by reacting with –OH of polymers through hydrolysis, followed by condensation. Considering 
the aforementioned characteristics, we decided to use GLYMO as an adhesive to covalently link 
between i) the GLYMO-functionalized PETE membrane (GLYMO-PETE) and the hydroxyl-
functionalized PMMA (OH-PMMA). In addition, we also treated ii) the PETE membranes with APTES 
(APTES-PETE) to compare the bonding strength with the GLYMO-treated PETE membranes, and 
predicted that the bonding of GLYMO-PETE to OH-PMMA would be much stronger than APTES-
PETE to OH-PMMA. This prediction can be attributed to the fact that the hydroxyl groups on plasma-
treated PMMA have higher reactivity toward the epoxide groups on GLYMO-PETE than to the amine 
groups from APTES-PETE. Finally, we also attempted to bond iii) the GLYMO treated PETE 
membranes (GLYMO-PETE) to the APTES-functionalized PMMA substrates (APTES-PMMA) 
because amine groups in APTES are known to be reactive with epoxide groups in GLYMO. 
In order to validate our bonding strategy between the PETE membranes and the PMMA substrates, we 
first characterized the surface functionalization by obtaining SEM images, contact angles, and XPS 
measurement of the membrane when in bare form, air plasma-treated and GLYMO-treated. SEM 
images confirmed that the porous structures of the track-etched PETE membranes were completely 
retained even after GLYMO treatment and heating at 100 oC for 2 min (Fig. 3). The water contact angles 
measured on the bare PETE membrane surface, the air-plasma treated surface, and the 5% GLYMO 
treated surface were 98.443o ± 0.651o, 46.146o ± 1.342o, and 82.911o ± 1.004o, respectively (Fig. 4). This 
indicates the topography change after plasma and chemical treatment where the plasma-treated surface 
became more hydrophilic and after coated with GLYMO, it became more hydrophobic but not as much 
as in the bare form. The siloxane groups (Si2s and Si2p) shown in the XPS spectra supported the 
successful functionalization of GLYMO on the PETE surface (Fig. 5). For more quantitative analysis 
of the surface functionalization, we assessed the inherent density of the elements on the PETE and 
PMMA surfaces using FT-IR analysis. The higher peak intensity in the FT-IR spectra represents the 
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higher density of a functional group associated with a certain molecular bond. It is noticeable that there 
was a drastic increase in the proportion of C-H, C=O, C-O bonds in i) the GLYMO-treated membranes 
in comparison to ii) the APTES-treated PETE membranes (Fig.6). In addition, iii) the PMMA substrates 
treated with APTES (APTES-PMMA) yielded a lower peak intensity than the air-plasma treated PMMA 
substrates (OH-PMMA), which implies that the number of amine groups formed on the PMMA surface 
is smaller than that of hydroxyl groups on the surface driven by air plasma treatment. Hence, as more 
epoxide groups on the GLYMO-treated PETE membrane were available for bonding with hydroxyl 
groups on the PMMA substrates, we predicted that the stronger bond strength would be achieved 






















Figure 3. Surface characterization of PETE membrane after chemical treatment. (A)-(I) SEM images 
of the porous PETE membrane when in bare condition, air plasma-treated, and GLYMO-treated. Scale 
bar, 100 µm (A), (D), (G); 50 µm in (B), (E), (H); 10 µm in (C), (F), (I). Contact angles were also 




Figure 4. (A) XPS analysis of the GLYMO - treated PETE membrane. (B) The SiC bond is derived 
from the GLYMO molecules. (C), (D) The C 1s and O 1s spectra showing multiple peaks represent 















Figure 5. FT-IR analysis of (A) GLYMO-treated PETE membrane and (B) APTES-treated PETE 
membrane compared against air-plasma treated PETE membrane, respectively. (C) FT-IR analysis of  
APTES-treated PMMA substrate versus air plasma-treated PETE membrane.  
 
3.2 Bonding strength evaluation  
We compared the bonding strength between the PETE membranes and the PMMA substrates, achieved 
by various chemical bonding strategies including i) GLYMO-PETE to OH-PMMA, ii) APTES-PETE 
to OH-PMMA, and iii) GLYMO-PETE to APTES-PMMA. As shown in Fig. 6, the shear stress endured 
by i) GLYMO-PETE to OH-PMMA was around 1.97 x 107 kg/m2, which is much greater than the other 
two experimental conditions (ii, APTES-PETE to OH-PMMA: 1.33 x 107 kg/m2 and iii, GLYMO-PETE 
to APTES-PMMA: 1.14 x 107 kg/m2). As we predicted, the bonding between GLYMO-PETE and OH-
PMMA provided a stronger and more robust bonding than the other cases. This higher reactivity is 
presumably due to the higher bioreactivity of the hydroxyl group (-OH) of the PMMA substrates to an 
epoxide group in GLYMO than when reacting to the amine group (–NH2) from APTES coated on PETE 
membrane. However, contradicting our prediction, the bonding strength between GLYMO-PETE to 
APTES-PMMA was not as high as that of GLYMO-PETE to OH-PMMA because of the density of 
amine groups formed on the PMMA substrate was much lower than hydroxyl groups on the air-plasma 
treated PMMA substrates. We tested various concentrations of GLYMO and APTES to functionalize 
the surface in a range of 1 ~ 5 %, treating the PETE surface with 5% GLYMO resulted in the strongest 
bonding with the PMMA substrates (Data not shown). In addition, we validate the robust bonding by 
conducting a leakage test. We flowed the color-dyed solution through the microfluidic channel and 
increase the internal pressure gradually all while clamping the Tygon tube at the outlets. The device 
could endure up to above 135 kPa of gauge pressure (the upper limit of the pressure sensor) without 
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any bursts. No leakage was found in the device even when we continuously flowed the solution for four 









Figure 6. Validation of robust bonding. (A) Bonding strength between PMMA and PETE membrane 
was measured in term of shear stress. GLYMO-coated PETE bonded to hydroxylated PMMA 
substrates showed the highest resistance to shear force compared to other bonding methods. (B)(C)(D) 





3.3 Cell culture and cytotoxicity testing of drug  
To test the compatibility of the PMMA or PDMS devices with cell culture, we seeded human lung 
adenocarcinoma cells on the track-etched PETE porous membranes incorporated inside the microfluidic 
devices and allowed them to proliferate up to 7 days. While the PMMA device showed a clear and flat 
PETE membrane surface, the membranes integrated into the PDMS device were found wrinkled and 
warped, which is most likely due to the difference in the thermal expansion coefficient between the 
PETE membrane and the PDMS substrates (Fig. 7 A, B). This uneven membrane surface could hinder 
the imaging process. As shown in Fig. 7 C (left), cancer cells (A549) were well seeded inside the PMMA 
chip and easily recognized under a microscope whereas the entire cell images in the PDMS chip cannot 
be acquired at a certain focal plane due to the irregularly deformed membrane structures. Primary cells 
(HUVEC) were also seeded and similar difficulty was encountered (data not shown). Moreover, the 
irregular surface area of the membranes could significantly affect analytical outcomes because most 
cell toxicity and membrane permeability are often normalized to the surface area of the membranes. 
The difference between PMMA and PDMS chip was also apparent in terms of small molecule 
absorption. When a dye-penetration test was conducted and hourly fluorescent pictures were taken, 
PDMS was shown to absorb much more dye at 4 hr time point compared to how much PMMA substrates 
absorb at 16 hr (Fig. 8). Hence, we predicted that there would be a similar result in the cytotoxicity test 
with drugs. 
We observed the cytotoxicity response of human lung adenocarcinoma cells to an anticancer drug 
(vincristine) after 48 hr of treatment in the PMMA and PDMS devices. The cytotoxicity of the cells 
cultured in the PMMA and PDMS devices showed a significant difference (P<0.05) when they were 
treated with 300 nM of vincristine as shown in Fig. 9 (the cell viability of 99.51 ± 0.27% and 85.43 ± 
2.25 %, respectively). This can be explained as a considerable amount of vincristine has been absorbed 
into PDMS due to the intrinsic hydrophobic molecular characteristics (LogP = 2.82), which, in turn, 
resulted in a reduction of the drug concentration below 300 nM in the culture medium, and thus 
increased the cell viability of the cells treated in the PDMS device. Interestingly, when the cells were 
treated with a relatively higher concentration (1 µM), the difference in the cytotoxicity between the 
PMMA and PDMS devices became insignificant (Fig. 9). This is because the amount of vincristine 
absorbed into PDMS becomes negligible in a relatively higher drug concentration. The critical 
concentration for cells cultured in the PDMS device to be affected by the drug was not calculated since 
it is dependent on chip design and surface area. In addition, we also tested the cytotoxicity of vincristine 
in the PDMS devices, which were made by PDMS prepared with various ratios of PDMS precursors 
and a curing reagent (5:1, 10:1, 20:1); however, these were not apparent to a degree of reduction in the 
drug concentrations (data not shown). Given the results we obtained above, the material property of the 
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microfluidic cytotoxicity devices, including the thermal expansion coefficient and drug absorption, 
would be of significant concern when we have to discriminate subtle differences in drug toxicity at 
relatively low concentrations in the device.  
Figure 7. Diagrammatic top-view representations of the microfluidic channels and PETE membranes 
assembled with PMMA and PDMS. Scale bars, 400 μm. (A) The flat PETE membrane in the PMMA – 
PETE device. (B) The irregularly wrinkled PETE membrane in the PDMS – PETE device. (C) Confocal 
microscopic images (orthogonal section display mode) showing calcein-AM-stained human lung 
adenocarcinoma cells (green) cultured for 2 days on PETE membrane in the PMMA and PDMS devices, 
respectively. The two inset panels at the top and right sides of the images depict the longitudinal and 















Figure 8. Small molecule absorption degree evaluation using dye-penetration test. (A) Rhodamine B solution 
was flowed through the PDMS-PETE and PMMA-PETE channel for 4 to 16 hours. The fluorescence images 
captured from the top view shows dye solution absorpted into the substrates at each different time point. Neither 
PMMA nor PETE absorbed the rhodamine B dye while the PDMS significantly absorbed the dye. The 
fluorescence intensity of the PETE membrane (bottom panel of A) was measured after washing out the channel 
with a buffer solution to remove residual rhodamine B dyes in the channel. Scale bar: 200 µm. (B) The 


















Figure 9. Cytotoxicity testing of Vincristine (at 300nM and 1 μM concentration) on human lung 





In this work, we proposed a method to chemically bond PMMA substrates to porous PETE track-etched 
membranes to achieve a robust microfluidic device for cytotoxicity tests of anticancer drugs. The PETE 
membrane-integrated PMMA devices enabled a flat and uniform porous membrane and reliable delivery 
of drugs at a targeted concentration to the cells. We demonstrated that GLYMO-PETE bonded with OH-
PMMA yield the strongest bonding strength compared to other chemical bonding strategies, including 
conventional coupling reagent APTES. We could further explore potential pairs of chemical reagents 
that allow to bond different polymer or inorganic substrates to fabricate the microfluidic devices that 
permit various capabilities. To extent usability of organ-on-a-chip or lab on a chip for more practical 
applications, we believe that our method will provide the great capability to researchers in the field to 
explore cell and tissue engineering in various conditions more precisely mimicking the micro-





















1. Matteelli, A. et al. Multidrug-resistant and extensively drug-resistant Mycobacterium 
tuberculosis: Epidemiology and control. Expert Rev. Anti. Infect. Ther. 5, 857–871 (2007). 
2. Linker, R. The Drug discovery market. https://www.globenewswire.com/news-
release/2020/09/16/2094263/0/en/The-drug-discovery-services-market-is-projected-to-reach-
USD-21-4-billion-by-2025-from-USD-11-1-billion-in-2020-at-a-CAGR-of-14-
0.html#:~:text=Filings Media Partners-,The drug discovery services market is projected to reach 
USD,at a CAGR of 14.0%25 (2020). 
3. Streets, A. M. & Huang, Y. Chip in a lab: Microfluidics for next generation life science research. 
Biomicrofluidics 7, (2013). 
4. Ma, B., Zhang, G., Qin, J. & Lin, B. Characterization of drug metabolites and cytotoxicity assay 
simultaneously using an integrated microfluidic device. Lab Chip 9, 232–238 (2009). 
5. Jastrzebska, E. et al. A microfluidic system to study the cytotoxic effect of drugs: The combined 
effect of celecoxib and 5-fluorouracil on normal and cancer cells. Microchim. Acta 180, 895–
901 (2013). 
6. Mata, A., Fleischman, A. J. & Roy, S. Characterization of Polydimethylsiloxane (PDMS) 
Properties for Biomedical Micro/Nanosystems. Biomed. Microdevices 7, 281–293 (2005). 
7. Toepke, M. W. & Beebe, D. J. PDMS absorption of small molecules and consequences in 
microfluidic applications. 1484–1486 (2006) doi:10.1039/b612140c. 
8. Ali, U., Karim, K. J. B. A. & Buang, N. A. A Review of the Properties and Applications of Poly 
(Methyl Methacrylate) (PMMA). Polym. Rev. 55, 678–705 (2015). 
9. Zhu, X., Liu, G., Guo, Y. & Tian, Y. Study of PMMA thermal bonding. Microsyst. Technol. 13, 
403–407 (2007). 
10. Song, I. H. & Park, T. PMMA solution assisted room temperature bonding for PMMA-PC hybrid 
devices. Micromachines 8, 1–6 (2017). 
11. Yussuf, A. A., Sbarski, I., Hayes, J. P., Solomon, M. & Tran, N. Microwave welding of 
polymeric-microfluidic devices. J. Micromechanics Microengineering 15, 1692–1699 (2005). 
12. Dang, F. et al. Replica multichannel polymer chips with a network of sacrificial channels sealed 
by adhesive printing method. Lab Chip 5, 472–478 (2005). 
13. Bamshad, A., Nikfarjam, A. & Khaleghi, H. A new simple and fast thermally-solvent assisted 











Throughout the master’s degree program, I have received a great deal of support and assistance. 
First of all, I would like to express my gratitude to my supervisor, Professor Kang Joo Hun for his kind 
guidance and constant supervision ever since I started my internship in TMB lab in 2016. I would also 
like to thank Professor Ahn Suk-kyun, Professor Choi Sungyoung for providing me opportunities to 
collaborate on interesting projects and continuously expand my horizon of knowledge. Thank you to 
Professor Park Tae Eun for not only be being an instructor, a collaborator but also an inspiring example 
of a resilient and passionate female scientist.  
While working on my research, I made many friends, whose supports were fuel to my growth in the 
past couple of years.  
To Amanzhol, thank you for being my academic and life advisor, regardless of the topics, your insightful 
advice would always help me get back on my feet and push harder. You are my ride or die and I know 
for a fact that we would always have each other’s backs no matter how far we are apart. Words cannot 
describe how much I am grateful for you, and for that, you deserve to be the Godfather of my future 
children.  
To Suhyun, Minseok, Jungwon, and Brian, thank you for being my enthusiastic colleagues. I learned a 
great deal while working closely with you guys. Your feedback sharpened my thinking and brought my 
work to a higher level.  
To Bonghwan, Sungjin, Ji-ung, Sim seonsengnim, and Professor Kwon, thank you for caring for me. 
You will always be a second family in my heart.   
To my dear friends Sasha, Madina, I adore you girls so much and thank you for being by my side since 
undergraduate time. Together with Anchik, Almas, and Kat, we had two amazing (and safe) trips amid 
the crazy Corona pandemic and I would never forget these memories. I wish we could come together 
one day and have an adventurous trip again.  
My special thanks go to my boyfriend, Valentyn Visyn. Your endless love, support, humor are treasures. 
Thank you for believing in me even when I doubt myself the most. Thank you for the stimulating 
discussions on anything and everything. I love our phenomenon food tour and consistent sessions of 
rowing, hiking, cycling, skateboarding, (attempted) pull-ups. They were indeed happy distractions to 
rest my mind outside of research. “Don’t know where the path leads but happy to walk with you”. 
 
Quoting all of my other friends would be too long, but thank you and I love you all.   
32 
 
My biggest thank-you is for my family. Mom, dad, and Hieu, you are the reason I choose to keep my 
head up and move forward. Your relentless love is everything that made me who I am today. I know I 
can be quite a handful sometimes but deep down I am forever grateful and proud to call you guys my 
family. I promise I love you so much more than you will ever know.  
Lastly, I would like to thank myself. Thank you for stop self - sabotaging and instead open up to the 
growth opportunities every day. With so much uncertainty to come in the future, I owe it up to my future 
self to work harder, dig deep, constantly edit self-identity, and make my past self proud of who we have 
become. For that, I say thank you.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
